Single Nucleotide Polymorphism in the Promoter Region of H1 Histone Family Member N, Testis-specific (H1FNT) and Its Association Study with Male Infertility.
('Single', 'Single', 'JJ', 'B-NP', 'O')
('Nucleotide', 'Nucleotide', 'NN', 'I-NP', 'O')
('Polymorphism', 'Polymorphism', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Promoter', 'Promoter', 'NN', 'I-NP', 'B-DNA')
('Region', 'Region', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('H1', 'H1', 'NN', 'B-NP', 'B-protein')
('Histone', 'Histone', 'NNP', 'I-NP', 'I-protein')
('Family', 'Family', 'NNP', 'I-NP', 'I-protein')
('Member', 'Member', 'NNP', 'I-NP', 'I-protein')
('N,', 'N,', 'NNP', 'I-NP', 'O')
('Testis-specific', 'Testis-specific', 'JJ', 'I-NP', 'O')
('(H1FNT)', '(H1FNT)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Its', 'Its', 'PRP$', 'B-NP', 'O')
('Association', 'Association', 'NNP', 'I-NP', 'O')
('Study', 'Study', 'NNP', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('Male', 'Male', 'NNP', 'B-NP', 'O')
('Infertility.', 'Infertility.', 'NNP', 'I-NP', 'O')
The H1 histone family, member N, testisspecific (H1FNT) is exclusively expressed in the testis, and had its possible role for sperm chromatin formation.
('The', 'The', 'DT', 'B-NP', 'O')
('H1', 'H1', 'NN', 'I-NP', 'O')
('histone', 'histone', 'NN', 'I-NP', 'O')
('family,', 'family,', 'NN', 'I-NP', 'O')
('member', 'member', 'NN', 'I-NP', 'O')
('N,', 'N,', 'NN', 'I-NP', 'O')
('testisspecific', 'testisspecific', 'JJ', 'I-NP', 'O')
('(H1FNT)', '(H1FNT)', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('exclusively', 'exclusively', 'RB', 'I-VP', 'O')
('expressed', 'express', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('testis,', 'testis,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('possible', 'possible', 'JJ', 'I-NP', 'O')
('role', 'role', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('sperm', 'sperm', 'NN', 'B-NP', 'B-protein')
('chromatin', 'chromatin', 'NN', 'I-NP', 'I-protein')
('formation.', 'formation.', 'NN', 'I-NP', 'O')
The purpose of this study is to investigate any genetic association of H1FNT gene with male infertility, especially at the promoter region.
('The', 'The', 'DT', 'B-NP', 'O')
('purpose', 'purpose', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('investigate', 'investigate', 'VB', 'I-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'B-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility,', 'infertility,', 'NN', 'I-NP', 'O')
('especially', 'especially', 'RB', 'B-ADVP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'O')
('region.', 'region.', 'NN', 'I-NP', 'O')
We examined the promoter single nucleotide polymorphisms (SNP) of H1FNT gene which is located within transcription factor binding site for its association with male infertility.
('We', 'We', 'PRP', 'B-NP', 'O')
('examined', 'examine', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'B-DNA')
('single', 'single', 'JJ', 'I-NP', 'O')
('nucleotide', 'nucleotide', 'NN', 'I-NP', 'O')
('polymorphisms', 'polymorphism', 'NNS', 'I-NP', 'O')
('(SNP)', '(SNP)', 'NN', 'I-NP', 'B-protein')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'B-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('which', 'which', 'WDT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('located', 'located', 'JJ', 'B-ADJP', 'O')
('within', 'within', 'IN', 'B-PP', 'O')
('transcription', 'transcription', 'NN', 'B-NP', 'B-DNA')
('factor', 'factor', 'NN', 'I-NP', 'I-DNA')
('binding', 'binding', 'NN', 'I-NP', 'I-DNA')
('site', 'site', 'NN', 'I-NP', 'I-DNA')
('for', 'for', 'IN', 'B-PP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility.', 'infertility.', 'NN', 'I-NP', 'O')
The statistical analysis showed that the −1129A＞T polymorphism was present at a statistically significance in male infertility (p= 0.0059 and 0.0349 for hetero and risk type, respectively).
('The', 'The', 'DT', 'B-NP', 'O')
('statistical', 'statistical', 'JJ', 'I-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'B-DNA')
('polymorphism', 'polymorphism', 'NN', 'I-NP', 'I-DNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('present', 'present', 'JJ', 'B-ADJP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('statistically', 'statistically', 'RB', 'I-NP', 'O')
('significance', 'significance', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility', 'infertility', 'NN', 'I-NP', 'O')
('(p=', '(p=', 'NN', 'I-NP', 'O')
('0.0059', '0.0059', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('0.0349', '0.0349', 'CD', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('hetero', 'hetero', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('risk', 'risk', 'NN', 'I-NP', 'O')
('type,', 'type,', 'NN', 'I-NP', 'O')
('respectively).', 'respectively).', 'NN', 'I-NP', 'O')
The dual-luciferase promoter assay was performed to examine the polymorphic effect of this promoter SNP by the cloning of promoter region (1700bp fragment) into pGL3-basic vector.
('The', 'The', 'DT', 'B-NP', 'O')
('dual-luciferase', 'dual-luciferase', 'NN', 'I-NP', 'B-DNA')
('promoter', 'promoter', 'NN', 'I-NP', 'I-DNA')
('assay', 'assay', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('examine', 'examine', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('polymorphic', 'polymorphic', 'JJ', 'I-NP', 'O')
('effect', 'effect', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cloning', 'cloning', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('promoter', 'promoter', 'NN', 'B-NP', 'O')
('region', 'region', 'NN', 'I-NP', 'O')
('(1700bp', '(1700bp', 'NN', 'I-NP', 'O')
('fragment)', 'fragment)', 'NN', 'I-NP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('pGL3-basic', 'pGL3-basic', 'JJ', 'B-NP', 'O')
('vector.', 'vector.', 'NN', 'I-NP', 'O')
In our plasmid based reporter system, there is no big difference between wild and risk type.
('In', 'In', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('plasmid', 'plasmid', 'NN', 'I-NP', 'O')
('based', 'based', 'JJ', 'I-NP', 'O')
('reporter', 'reporter', 'NN', 'I-NP', 'O')
('system,', 'system,', 'NN', 'I-NP', 'O')
('there', 'there', 'EX', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('big', 'big', 'JJ', 'I-NP', 'O')
('difference', 'difference', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('wild', 'wild', 'JJ', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('risk', 'risk', 'NN', 'I-NP', 'O')
('type.', 'type.', 'NN', 'I-NP', 'O')
In conclusion, H1FNT −1129A＞T promoter SNP is statistically significant with male infertility, especially with subfertile (non-azoospermia) group.
('In', 'In', 'IN', 'B-PP', 'O')
('conclusion,', 'conclusion,', 'NN', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('statistically', 'statistically', 'RB', 'B-ADJP', 'O')
('significant', 'significant', 'JJ', 'I-ADJP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility,', 'infertility,', 'NN', 'I-NP', 'O')
('especially', 'especially', 'RB', 'B-ADVP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('subfertile', 'subfertile', 'JJ', 'B-NP', 'O')
('(non-azoospermia)', '(non-azoospermia)', 'NN', 'I-NP', 'O')
('group.', 'group.', 'NN', 'I-NP', 'O')
Further analysis of its functional polymorphic effect in vivo may provide the biological significance of testis-specific histone with spermatogenesis.
('Further', 'Further', 'JJ', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('functional', 'functional', 'JJ', 'I-NP', 'O')
('polymorphic', 'polymorphic', 'JJ', 'I-NP', 'O')
('effect', 'effect', 'NN', 'I-NP', 'O')
('in', 'in', 'FW', 'B-ADVP', 'O')
('vivo', 'vivo', 'FW', 'I-ADVP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('provide', 'provide', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('biological', 'biological', 'JJ', 'I-NP', 'O')
('significance', 'significance', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('testis-specific', 'testis-specific', 'JJ', 'B-NP', 'B-protein')
('histone', 'histone', 'NN', 'I-NP', 'I-protein')
('with', 'with', 'IN', 'B-PP', 'O')
('spermatogenesis.', 'spermatogenesis.', 'NN', 'B-NP', 'O')
H1 histone family, member N, testis-specific (H1FNT) is exclusively expressed in the testis with a correlation of its histone like role during the spermatogenesis (Tanaka et al., 2006).
('H1', 'H1', 'NN', 'B-NP', 'O')
('histone', 'histone', 'NN', 'I-NP', 'O')
('family,', 'family,', 'NN', 'I-NP', 'O')
('member', 'member', 'NN', 'I-NP', 'O')
('N,', 'N,', 'NN', 'I-NP', 'O')
('testis-specific', 'testis-specific', 'JJ', 'I-NP', 'O')
('(H1FNT)', '(H1FNT)', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('exclusively', 'exclusively', 'RB', 'I-VP', 'O')
('expressed', 'express', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('testis', 'testis', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('correlation', 'correlation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('histone', 'histone', 'NN', 'I-NP', 'B-protein')
('like', 'like', 'IN', 'B-PP', 'O')
('role', 'role', 'NN', 'B-NP', 'O')
('during', 'during', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('spermatogenesis', 'spermatogenesis', 'NN', 'I-NP', 'O')
('(Tanaka', '(Tanaka', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2006).', '2006).', 'CD', 'B-NP', 'O')
The H1FNT is essential for normal spermatogenesis and male fertility (Martianov et al., 2005; Tanaka et al., 2005).
('The', 'The', 'DT', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('essential', 'essential', 'JJ', 'B-ADJP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('normal', 'normal', 'JJ', 'B-NP', 'O')
('spermatogenesis', 'spermatogenesis', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('fertility', 'fertility', 'NN', 'I-NP', 'O')
('(Martianov', '(Martianov', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2005;', '2005;', ':', 'O', 'O')
('Tanaka', 'Tanaka', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2005).', '2005).', 'CD', 'B-NP', 'O')
The human H1FNT is reported to be important in the sperm chromatin formation (Tanaka et al., 2006).
('The', 'The', 'DT', 'B-NP', 'O')
('human', 'human', 'JJ', 'I-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('important', 'important', 'JJ', 'B-ADJP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('sperm', 'sperm', 'NN', 'I-NP', 'O')
('chromatin', 'chromatin', 'NN', 'I-NP', 'O')
('formation', 'formation', 'NN', 'I-NP', 'O')
('(Tanaka', '(Tanaka', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2006).', '2006).', 'CD', 'B-NP', 'O')
In the spermiogenesis, the physiological role of the H1FNT is related with the chromatin condensation (Tanaka et al., 2005).
('In', 'In', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('spermiogenesis,', 'spermiogenesis,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('physiological', 'physiological', 'JJ', 'I-NP', 'O')
('role', 'role', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('related', 'related', 'JJ', 'B-ADJP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('chromatin', 'chromatin', 'NN', 'I-NP', 'B-DNA')
('condensation', 'condensation', 'NN', 'I-NP', 'O')
('(Tanaka', '(Tanaka', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2005).', '2005).', 'CD', 'B-NP', 'O')
With the homozygous Hanp1/H1T2 (mouse H1FNT) knockout mice study, there was abnormal chromatin packing and nuclear formation in the sperm (Kimura et al., 2003).
('With', 'With', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('homozygous', 'homozygous', 'JJ', 'I-NP', 'O')
('Hanp1/H1T2', 'Hanp1/H1T2', 'NN', 'I-NP', 'O')
('(mouse', '(mouse', 'NN', 'I-NP', 'O')
('H1FNT)', 'H1FNT)', 'NN', 'I-NP', 'O')
('knockout', 'knockout', 'NN', 'I-NP', 'O')
('mice', 'mouse', 'NNS', 'I-NP', 'O')
('study,', 'study,', 'VBD', 'B-VP', 'O')
('there', 'there', 'EX', 'B-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('abnormal', 'abnormal', 'JJ', 'B-NP', 'O')
('chromatin', 'chromatin', 'NN', 'I-NP', 'O')
('packing', 'packing', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('nuclear', 'nuclear', 'JJ', 'B-NP', 'O')
('formation', 'formation', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('sperm', 'sperm', 'NN', 'I-NP', 'B-cell_type')
('(Kimura', '(Kimura', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2003).', '2003).', 'CD', 'B-NP', 'O')
Male infertility is reported in case of the homozygous Hanp1/H1T2 mutant male mice with abnormal sperm morphology and the reduced sperm motility (Miyagawa et al., 2005; Tanaka et al., 2003).
('Male', 'Male', 'JJ', 'B-NP', 'O')
('infertility', 'infertility', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('case', 'case', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('homozygous', 'homozygous', 'JJ', 'I-NP', 'O')
('Hanp1/H1T2', 'Hanp1/H1T2', 'NN', 'I-NP', 'O')
('mutant', 'mutant', 'JJ', 'I-NP', 'O')
('male', 'male', 'JJ', 'I-NP', 'O')
('mice', 'mouse', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('abnormal', 'abnormal', 'JJ', 'B-NP', 'O')
('sperm', 'sperm', 'NN', 'I-NP', 'O')
('morphology', 'morphology', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('reduced', 'reduce', 'VBN', 'I-NP', 'O')
('sperm', 'sperm', 'NN', 'I-NP', 'B-protein')
('motility', 'motility', 'NN', 'I-NP', 'I-protein')
('(Miyagawa', '(Miyagawa', 'NNP', 'I-NP', 'I-protein')
('et', 'et', 'NNP', 'I-NP', 'I-protein')
('al.,', 'al.,', 'VBD', 'B-VP', 'I-protein')
('2005;', '2005;', ':', 'O', 'I-protein')
('Tanaka', 'Tanaka', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2003).', '2003).', 'CD', 'B-NP', 'O')
H1FNT gene is located on the long arm of chromosome 12 (12q13.11), and has one exon spanning a length of 1,300bp, encodes a protein of approximately 255 amino acids.
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'B-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('is', 'be', 'VBZ', 'B-VP', 'O')
('located', 'located', 'JJ', 'B-ADJP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('long', 'long', 'JJ', 'I-NP', 'O')
('arm', 'arm', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('chromosome', 'chromosome', 'NN', 'B-NP', 'B-DNA')
('12', '12', 'CD', 'I-NP', 'I-DNA')
('(12q13.11),', '(12q13.11),', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('one', 'one', 'CD', 'B-NP', 'O')
('exon', 'exon', 'NN', 'I-NP', 'B-DNA')
('spanning', 'span', 'VBG', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('length', 'length', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('1,300bp,', '1,300bp,', 'NN', 'B-NP', 'B-DNA')
('encodes', 'encode', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('protein', 'protein', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('approximately', 'approximately', 'RB', 'B-NP', 'O')
('255', '255', 'CD', 'I-NP', 'O')
('amino', 'amino', 'NN', 'I-NP', 'O')
('acids.', 'acids.', 'NN', 'I-NP', 'O')
Previous SNP analysis of H1FNT gene showed that five common cSNPs (coding SNP) showed no genetic association with male infertility from Japan (Tanaka et al., 2006).
('Previous', 'Previous', 'JJ', 'B-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'B-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('showed', 'show', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('five', 'five', 'CD', 'B-NP', 'O')
('common', 'common', 'JJ', 'I-NP', 'O')
('cSNPs', 'cSNP', 'NNS', 'I-NP', 'O')
('(coding', '(code', 'VBG', 'B-VP', 'O')
('SNP)', 'SNP)', 'NN', 'B-NP', 'B-protein')
('showed', 'show', 'VBD', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility', 'infertility', 'NN', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('Japan', 'Japan', 'NNP', 'B-NP', 'O')
('(Tanaka', '(Tanaka', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2006).', '2006).', 'CD', 'B-NP', 'O')
Since H1FNT is the testis specific histone gene, so we investigated any genetic variation in promoter region of the H1FNT with male infertility from Korea population.
('Since', 'Since', 'IN', 'B-SBAR', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('testis', 'testis', 'NN', 'I-NP', 'O')
('specific', 'specific', 'JJ', 'I-NP', 'O')
('histone', 'histone', 'NN', 'I-NP', 'O')
('gene,', 'gene,', 'NN', 'I-NP', 'O')
('so', 'so', 'IN', 'B-SBAR', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('investigated', 'investigate', 'VBD', 'B-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('variation', 'variation', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('promoter', 'promoter', 'NN', 'B-NP', 'B-DNA')
('region', 'region', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility', 'infertility', 'NN', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('Korea', 'Korea', 'NNP', 'B-NP', 'O')
('population.', 'population.', 'NN', 'I-NP', 'O')
We also investigated any polymorphism effect of statistically significant promoter SNP, and analyzed its clinical significance of testis specific histone.
('We', 'We', 'PRP', 'B-NP', 'O')
('also', 'also', 'RB', 'B-ADVP', 'O')
('investigated', 'investigate', 'VBD', 'B-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('polymorphism', 'polymorphism', 'NN', 'I-NP', 'O')
('effect', 'effect', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('statistically', 'statistically', 'RB', 'B-NP', 'O')
('significant', 'significant', 'JJ', 'I-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'O')
('SNP,', 'SNP,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('analyzed', 'analyze', 'VBD', 'B-VP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('clinical', 'clinical', 'JJ', 'I-NP', 'O')
('significance', 'significance', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('testis', 'testis', 'NN', 'B-NP', 'O')
('specific', 'specific', 'JJ', 'I-NP', 'O')
('histone.', 'histone.', 'NN', 'I-NP', 'O')
Two hundred three healthy fertile men who had at least one child and who lacked any history of requiring assisted reproduction technology were included as the nationwide control group.
('Two', 'Two', 'CD', 'B-NP', 'O')
('hundred', 'hundred', 'CD', 'I-NP', 'O')
('three', 'three', 'CD', 'I-NP', 'O')
('healthy', 'healthy', 'JJ', 'I-NP', 'O')
('fertile', 'fertile', 'JJ', 'I-NP', 'O')
('men', 'man', 'NNS', 'I-NP', 'O')
('who', 'who', 'WP', 'B-NP', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('at', 'at', 'IN', 'B-NP', 'O')
('least', 'least', 'JJS', 'I-NP', 'O')
('one', 'one', 'CD', 'I-NP', 'O')
('child', 'child', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('who', 'who', 'WP', 'B-NP', 'O')
('lacked', 'lack', 'VBD', 'B-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('history', 'history', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('requiring', 'require', 'VBG', 'B-VP', 'O')
('assisted', 'assist', 'VBN', 'B-NP', 'O')
('reproduction', 'reproduction', 'NN', 'I-NP', 'O')
('technology', 'technology', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('included', 'include', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('nationwide', 'nationwide', 'JJ', 'I-NP', 'O')
('control', 'control', 'NN', 'I-NP', 'O')
('group.', 'group.', 'NN', 'I-NP', 'O')
Members of this group were identified at the Division of Genome Resources, National Genome Research Institute, National Institute of Health, and Seoul, Korea.
('Members', 'Member', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('identified', 'identify', 'VBN', 'I-VP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Division', 'Division', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Genome', 'Genome', 'NNP', 'B-NP', 'O')
('Resources,', 'Resources,', 'NNP', 'I-NP', 'O')
('National', 'National', 'NNP', 'I-NP', 'O')
('Genome', 'Genome', 'NNP', 'I-NP', 'O')
('Research', 'Research', 'NNP', 'I-NP', 'O')
('Institute,', 'Institute,', 'NNP', 'I-NP', 'O')
('National', 'National', 'NNP', 'I-NP', 'O')
('Institute', 'Institute', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Health,', 'Health,', 'NNP', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Seoul,', 'Seoul,', 'NNP', 'B-NP', 'O')
('Korea.', 'Korea.', 'NNP', 'I-NP', 'O')
Two hundred twentynine nonazoospermia (subfertile) patients were recruited from the CHA General Hospital, College of Medicine, CHA University from January 2000 to August 2003, (Seoul, Korea).
('Two', 'Two', 'CD', 'B-NP', 'O')
('hundred', 'hundred', 'CD', 'I-NP', 'O')
('twentynine', 'twentynine', 'CD', 'I-NP', 'O')
('nonazoospermia', 'nonazoospermia', 'JJ', 'I-NP', 'O')
('(subfertile)', '(subfertile)', 'NN', 'I-NP', 'O')
('patients', 'patient', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('recruited', 'recruit', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('CHA', 'CHA', 'NNP', 'I-NP', 'O')
('General', 'General', 'NNP', 'I-NP', 'O')
('Hospital,', 'Hospital,', 'NNP', 'I-NP', 'O')
('College', 'College', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Medicine,', 'Medicine,', 'NNP', 'B-NP', 'O')
('CHA', 'CHA', 'NNP', 'I-NP', 'O')
('University', 'University', 'NNP', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('January', 'January', 'NNP', 'B-NP', 'O')
('2000', '2000', 'CD', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('August', 'August', 'NNP', 'B-NP', 'O')
('2003,', '2003,', 'CD', 'I-NP', 'O')
('(Seoul,', '(Seoul,', 'NNP', 'I-NP', 'O')
('Korea).', 'Korea).', 'NNP', 'I-NP', 'O')
Semen analysis was performed with infertile males further subdivided following semen analysis performed strictly according to the World Health Organization (WHO) guidelines (WHO) (2001).
('Semen', 'Semen', 'NN', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('infertile', 'infertile', 'JJ', 'B-NP', 'O')
('males', 'male', 'NNS', 'I-NP', 'O')
('further', 'further', 'RBR', 'B-ADJP', 'O')
('subdivided', 'subdivide', 'VBN', 'I-ADJP', 'O')
('following', 'follow', 'VBG', 'B-PP', 'O')
('semen', 'seman', 'NNS', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('performed', 'perform', 'VBD', 'B-VP', 'O')
('strictly', 'strictly', 'RB', 'I-VP', 'O')
('according', 'accord', 'VBG', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('World', 'World', 'NNP', 'I-NP', 'O')
('Health', 'Health', 'NNP', 'I-NP', 'O')
('Organization', 'Organization', 'NNP', 'I-NP', 'O')
('(WHO)', '(WHO)', 'NNP', 'I-NP', 'O')
('guidelines', 'guideline', 'NNS', 'I-NP', 'O')
('(WHO)', '(WHO)', 'NNP', 'I-NP', 'O')
('(2001).', '(2001).', 'LS', 'O', 'O')
The subdivision    were azoospermia group (no spermatozoa in the ejaculate) and non-azoospermia group (low quality of spermatozoa in the ejaculate).
('The', 'The', 'DT', 'B-NP', 'O')
('subdivision', 'subdivision', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('azoospermia', 'azoospermia', 'NN', 'B-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('(no', '(no', 'VBP', 'B-VP', 'O')
('spermatozoa', 'spermatozoa', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ejaculate)', 'ejaculate)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('non-azoospermia', 'non-azoospermia', 'JJ', 'I-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('(low', '(low', 'VBP', 'B-VP', 'O')
('quality', 'quality', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('spermatozoa', 'spermatozoa', 'NN', 'B-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ejaculate).', 'ejaculate).', 'NN', 'I-NP', 'O')
All participants gave their written informed consent for participation in the study.
('All', 'All', 'DT', 'B-NP', 'O')
('participants', 'participant', 'NNS', 'I-NP', 'O')
('gave', 'give', 'VBD', 'B-VP', 'O')
('their', 'their', 'PRP$', 'B-NP', 'O')
('written', 'write', 'VBN', 'I-NP', 'O')
('informed', 'inform', 'VBN', 'I-NP', 'O')
('consent', 'consent', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('participation', 'participation', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('study.', 'study.', 'NN', 'I-NP', 'O')
The non-azoospermia group (n=229) was used for this study.
('The', 'The', 'DT', 'B-NP', 'O')
('non-azoospermia', 'non-azoospermia', 'JJ', 'I-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('(n=229)', '(n=229)', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study.', 'study.', 'NN', 'I-NP', 'O')
Exclusion criteria contains chromosome abnormality including Klinefelter syndrome (47, XXY) and Y chromosome microdeletion (Yun et al., 2008).
('Exclusion', 'Exclusion', 'NN', 'B-NP', 'O')
('criteria', 'criterion', 'NNS', 'I-NP', 'O')
('contains', 'contain', 'VBZ', 'B-VP', 'O')
('chromosome', 'chromosome', 'NN', 'B-NP', 'O')
('abnormality', 'abnormality', 'NN', 'I-NP', 'O')
('including', 'include', 'VBG', 'B-PP', 'O')
('Klinefelter', 'Klinefelter', 'NN', 'B-NP', 'O')
('syndrome', 'syndrome', 'NN', 'I-NP', 'O')
('(47,', '(47,', 'NN', 'I-NP', 'O')
('XXY)', 'XXY)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Y', 'Y', 'NN', 'B-NP', 'O')
('chromosome', 'chromosome', 'NN', 'I-NP', 'O')
('microdeletion', 'microdeletion', 'NN', 'I-NP', 'O')
('(Yun', '(Yun', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2008).', '2008).', 'CD', 'B-NP', 'O')
The PCR primers were designed using PRIMER3 site (http://frodo.
('The', 'The', 'DT', 'B-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'B-DNA')
('primers', 'primer', 'NNS', 'I-NP', 'I-DNA')
('were', 'be', 'VBD', 'B-VP', 'O')
('designed', 'design', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('PRIMER3', 'PRIMER3', 'NN', 'B-NP', 'B-DNA')
('site', 'site', 'NN', 'I-NP', 'I-DNA')
('(http://frodo.', '(http://frodo.', '.', 'O', 'O')
wi.
('wi.', 'wi.', 'LS', 'B-LST', 'O')
mit.
('mit.', 'mit.', 'LS', 'B-LST', 'O')
edu/primer3/) and pyrosequencing primers were designed PSQ assay design version 1.0 software.
('edu/primer3/)', 'edu/primer3/)', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('pyrosequencing', 'pyrosequencing', 'NN', 'I-NP', 'B-protein')
('primers', 'primer', 'NNS', 'I-NP', 'I-protein')
('were', 'be', 'VBD', 'B-VP', 'O')
('designed', 'design', 'VBN', 'I-VP', 'O')
('PSQ', 'PSQ', 'NN', 'B-NP', 'B-protein')
('assay', 'assay', 'NN', 'I-NP', 'O')
('design', 'design', 'NN', 'I-NP', 'O')
('version', 'version', 'NN', 'I-NP', 'O')
('1.0', '1.0', 'CD', 'B-NP', 'O')
('software.', 'software.', 'NN', 'I-NP', 'O')
The PCR was carried out using 30ng of genomic DNA and 10pmol each of the forward and reverse oligonucleotide PCR primers (Integrated Bioneer, Daejeon, Korea).
('The', 'The', 'DT', 'B-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('carried', 'carry', 'VBN', 'I-VP', 'O')
('out', 'out', 'RP', 'B-PRT', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('30ng', '30ng', 'CD', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('genomic', 'genomic', 'JJ', 'B-NP', 'B-DNA')
('DNA', 'DNA', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'I-NP', 'O')
('10pmol', '10pmol', 'NN', 'I-NP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('forward', 'forward', 'JJ', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('reverse', 'reverse', 'JJ', 'I-NP', 'O')
('oligonucleotide', 'oligonucleotide', 'NN', 'I-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'O')
('primers', 'primer', 'NNS', 'I-NP', 'O')
('(Integrated', '(Integrated', 'NNP', 'B-NP', 'O')
('Bioneer,', 'Bioneer,', 'NNP', 'I-NP', 'O')
('Daejeon,', 'Daejeon,', 'NNP', 'I-NP', 'O')
('Korea).', 'Korea).', 'NNP', 'I-NP', 'O')
These primers generate a 127bp fragment from nucleotide −1210 to −1083 upstream of the transcription start site.
('These', 'These', 'DT', 'B-NP', 'O')
('primers', 'primer', 'NNS', 'I-NP', 'O')
('generate', 'generate', 'VBP', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('127bp', '127bp', 'NN', 'I-NP', 'B-DNA')
('fragment', 'fragment', 'NN', 'I-NP', 'I-DNA')
('from', 'from', 'IN', 'B-PP', 'O')
('nucleotide', 'nucleotide', 'NN', 'B-NP', 'O')
('−1210', '−1210', 'CD', 'I-NP', 'O')
('to', 'to', 'TO', 'I-NP', 'O')
('−1083', '−1083', 'CD', 'I-NP', 'O')
('upstream', 'upstream', 'RB', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'O')
('start', 'start', 'NN', 'I-NP', 'O')
('site.', 'site.', 'NN', 'I-NP', 'O')
The following PCR conditions were used: predenaturation at 95oC for 5 minute, denaturation at 95oC for 1 minute, annealing at 52oC for 30 seconds, and extension at 72oC for 30 seconds for 35 cycles.
('The', 'The', 'DT', 'B-NP', 'O')
('following', 'follow', 'VBG', 'I-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'O')
('conditions', 'condition', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('used:', 'used:', 'JJ', 'B-NP', 'O')
('predenaturation', 'predenaturation', 'NN', 'I-NP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('95oC', '95oC', 'NN', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('5', '5', 'CD', 'B-NP', 'O')
('minute,', 'minute,', 'NN', 'I-NP', 'O')
('denaturation', 'denaturation', 'NN', 'I-NP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('95oC', '95oC', 'NN', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('1', '1', 'CD', 'B-NP', 'O')
('minute,', 'minute,', 'NN', 'I-NP', 'O')
('annealing', 'anneal', 'VBG', 'B-VP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('52oC', '52oC', 'NN', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('30', '30', 'CD', 'B-NP', 'O')
('seconds,', 'seconds,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('extension', 'extension', 'NN', 'I-NP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('72oC', '72oC', 'NN', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('30', '30', 'CD', 'B-NP', 'O')
('seconds', 'second', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('35', '35', 'CD', 'B-NP', 'O')
('cycles.', 'cycles.', 'NNS', 'I-NP', 'O')
The biotinylated PCR product then underwent pyrosequencing analysis for direct analysis of the −1129 polymorphism on PCR product according to the published method (Park et al., 2005; Yun et al., 2008).
('The', 'The', 'DT', 'B-NP', 'O')
('biotinylated', 'biotinylate', 'VBN', 'I-NP', 'B-protein')
('PCR', 'PCR', 'NN', 'I-NP', 'I-protein')
('product', 'product', 'NN', 'I-NP', 'I-protein')
('then', 'then', 'RB', 'B-ADVP', 'O')
('underwent', 'undergo', 'VBD', 'B-VP', 'O')
('pyrosequencing', 'pyrosequencing', 'NN', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('direct', 'direct', 'JJ', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('−1129', '−1129', 'CD', 'I-NP', 'O')
('polymorphism', 'polymorphism', 'NN', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('PCR', 'PCR', 'NN', 'B-NP', 'B-DNA')
('product', 'product', 'NN', 'I-NP', 'I-DNA')
('according', 'accord', 'VBG', 'B-PP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('published', 'publish', 'VBN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('(Park', '(Park', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2005;', '2005;', ':', 'O', 'O')
('Yun', 'Yun', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2008).', '2008).', 'CD', 'B-NP', 'O')
The sequences of all oligonucleotides in this study are listed in Table 1.
('The', 'The', 'DT', 'B-NP', 'O')
('sequences', 'sequence', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('all', 'all', 'DT', 'B-NP', 'O')
('oligonucleotides', 'oligonucleotide', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('listed', 'list', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Table', 'Table', 'JJ', 'B-NP', 'O')
('1.', '1.', 'CD', 'I-NP', 'O')
The genomic location of rs2261608 was indicated at Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('genomic', 'genomic', 'JJ', 'I-NP', 'O')
('location', 'location', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('rs2261608', 'rs2261608', 'NN', 'B-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('indicated', 'indicate', 'VBN', 'I-VP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('Fig.', 'Fig.', 'NNP', 'B-NP', 'O')
1.  rs2261608 is located at 1129 bp upstream of transcription start site of H1FNT1.
('1.', '1.', 'LS', 'B-NP', 'O')
('rs2261608', 'rs2261608', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('located', 'locate', 'VBN', 'I-VP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('1129', '1129', 'CD', 'B-NP', 'O')
('bp', 'bp', 'NN', 'I-NP', 'O')
('upstream', 'upstream', 'RB', 'B-ADVP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('transcription', 'transcription', 'NN', 'B-NP', 'B-DNA')
('start', 'start', 'NN', 'I-NP', 'I-DNA')
('site', 'site', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT1.', 'H1FNT1.', 'NN', 'B-NP', 'O')
The statistical analysis used to appraisal the odds ratio and 95% confidence intervals were SAS Enterprise Guide 4.
('The', 'The', 'DT', 'B-NP', 'O')
('statistical', 'statistical', 'JJ', 'I-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('used', 'use', 'VBN', 'B-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('appraisal', 'appraisal', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('odds', 'odd', 'NNS', 'I-NP', 'O')
('ratio', 'ratio', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('95%', '95%', 'NN', 'I-NP', 'O')
('confidence', 'confidence', 'NN', 'I-NP', 'O')
('intervals', 'interval', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('SAS', 'SAS', 'NNP', 'B-NP', 'O')
('Enterprise', 'Enterprise', 'NNP', 'I-NP', 'O')
('Guide', 'Guide', 'NNP', 'I-NP', 'O')
('4.', '4.', '.', 'O', 'O')
Results for the enumeration of data and comparison of percentages between groups were evaluated with a chi-squared test and Fisher’s exact test.
('Results', 'Result', 'NNS', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('enumeration', 'enumeration', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('data', 'datum', 'NNS', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('comparison', 'comparison', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('percentages', 'percentage', 'NNS', 'B-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('groups', 'group', 'NNS', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('evaluated', 'evaluate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('chi-squared', 'chi-squared', 'JJ', 'I-NP', 'O')
('test', 'test', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('Fisher’s', 'Fisher’', 'NNS', 'I-NP', 'O')
('exact', 'exact', 'VBP', 'B-VP', 'O')
('test.', 'test.', 'NN', 'B-NP', 'O')
Tests for the HardyWeinberg equilibrium and Odd ratios (OR) were implementation by the chisquared test.
('Tests', 'Test', 'NNS', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('HardyWeinberg', 'HardyWeinberg', 'NNP', 'I-NP', 'O')
('equilibrium', 'equilibrium', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('Odd', 'Odd', 'NN', 'I-NP', 'O')
('ratios', 'ratio', 'NNS', 'I-NP', 'O')
('(OR)', '(OR)', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('implementation', 'implementation', 'NN', 'B-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('chisquared', 'chisquared', 'JJ', 'I-NP', 'O')
('test.', 'test.', 'NN', 'I-NP', 'O')
The sperm parameter statistically analyzed with the Oneway ANOVA.
('The', 'The', 'DT', 'B-NP', 'O')
('sperm', 'sperm', 'NN', 'I-NP', 'O')
('parameter', 'parameter', 'NN', 'I-NP', 'O')
('statistically', 'statistically', 'RB', 'B-VP', 'O')
('analyzed', 'analyze', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Oneway', 'Oneway', 'NNP', 'I-NP', 'O')
('ANOVA.', 'ANOVA.', 'NNP', 'I-NP', 'O')
p values＜0.05 were taken as statistically significant.
('p', 'p', 'NN', 'B-NP', 'O')
('values＜0.05', 'values＜0.05', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('taken', 'take', 'VBN', 'I-VP', 'O')
('as', 'as', 'RB', 'B-VP', 'O')
('statistically', 'statistically', 'RB', 'I-VP', 'O')
('significant.', 'significant.', 'VB', 'I-VP', 'O')
For reporter assay, we constructed three reporters, pGL3Wild (−1129A), pGL3Risk (−1129T) and pGL3 Deletion (Δ−1129 to −1135) (Fig.
('For', 'For', 'IN', 'B-PP', 'O')
('reporter', 'reporter', 'NN', 'B-NP', 'O')
('assay,', 'assay,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('constructed', 'construct', 'VBD', 'B-VP', 'O')
('three', 'three', 'CD', 'B-NP', 'O')
('reporters,', 'reporters,', 'NN', 'I-NP', 'O')
('pGL3Wild', 'pGL3Wild', 'NN', 'I-NP', 'O')
('(−1129A),', '(−1129A),', 'NN', 'I-NP', 'O')
('pGL3Risk', 'pGL3Risk', 'NN', 'I-NP', 'O')
('(−1129T)', '(−1129T)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('pGL3', 'pGL3', 'NN', 'B-NP', 'O')
('Deletion', 'Deletion', 'NN', 'I-NP', 'O')
('(Δ−1129', '(Δ−1129', 'CD', 'B-NP', 'O')
('to', 'to', 'TO', 'I-NP', 'O')
('−1135)', '−1135)', 'CD', 'I-NP', 'O')
('(Fig.', '(Fig.', 'NNP', 'I-NP', 'O')
2A).
('2A).', '2A).', 'LS', 'B-LST', 'O')
By using the hH1FNT cloning primers, the genomic sequence from −2201 to ＋501 (1700 bp fragment) was amplified in the promoter region of H1FNT.
('By', 'By', 'IN', 'B-PP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('hH1FNT', 'hH1FNT', 'NN', 'I-NP', 'O')
('cloning', 'cloning', 'NN', 'I-NP', 'O')
('primers,', 'primers,', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('genomic', 'genomic', 'JJ', 'I-NP', 'B-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('from', 'from', 'IN', 'B-PP', 'O')
('−2201', '−2201', 'CD', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('＋501', '＋501', 'CD', 'B-NP', 'O')
('(1700', '(1700', 'CD', 'I-NP', 'O')
('bp', 'bp', 'NN', 'I-NP', 'O')
('fragment)', 'fragment)', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('amplified', 'amplify', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'B-DNA')
('region', 'region', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT.', 'H1FNT.', 'NN', 'B-NP', 'O')
pGL3Wild vector was constructed by cloning the amplification product into the pGL3Basic vector (Promega).
('pGL3Wild', 'pGL3Wild', 'NN', 'B-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('constructed', 'construct', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('cloning', 'clone', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('amplification', 'amplification', 'NN', 'I-NP', 'B-protein')
('product', 'product', 'NN', 'I-NP', 'I-protein')
('into', 'into', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('pGL3Basic', 'pGL3Basic', 'NN', 'I-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'O')
('(Promega).', '(Promega).', 'NN', 'I-NP', 'O')
The template DNA consisted of samples from individuals genotyped for the wild type.
('The', 'The', 'DT', 'B-NP', 'O')
('template', 'template', 'NN', 'I-NP', 'B-DNA')
('DNA', 'DNA', 'NN', 'I-NP', 'I-DNA')
('consisted', 'consist', 'VBD', 'B-VP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('samples', 'sample', 'NNS', 'B-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('individuals', 'individual', 'NNS', 'B-NP', 'O')
('genotyped', 'genotype', 'VBN', 'B-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('wild', 'wild', 'JJ', 'I-NP', 'O')
('type.', 'type.', 'NN', 'I-NP', 'O')
pGL3Risk and pGL3Dele (Deletion) vectors were constructed by Quik Change SiteDirected mutagenesis kit (Stratagene).
('pGL3Risk', 'pGL3Risk', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('pGL3Dele', 'pGL3Dele', 'NN', 'I-NP', 'O')
('(Deletion)', '(Deletion)', 'NN', 'I-NP', 'O')
('vectors', 'vector', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('constructed', 'construct', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('Quik', 'Quik', 'NNP', 'B-NP', 'O')
('Change', 'Change', 'NNP', 'I-NP', 'O')
('SiteDirected', 'SiteDirected', 'NNP', 'I-NP', 'O')
('mutagenesis', 'mutagenesis', 'NN', 'I-NP', 'O')
('kit', 'kit', 'NN', 'I-NP', 'O')
('(Stratagene).', '(Stratagene).', 'NNP', 'B-NP', 'O')
The mutagenesis primers were   designed by Agilent homepage (https://www.
('The', 'The', 'DT', 'B-NP', 'O')
('mutagenesis', 'mutagenesis', 'NN', 'I-NP', 'B-DNA')
('primers', 'primer', 'NNS', 'I-NP', 'I-DNA')
('were', 'be', 'VBD', 'B-VP', 'O')
('designed', 'design', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('Agilent', 'Agilent', 'JJ', 'B-NP', 'O')
('homepage', 'homepage', 'NN', 'I-NP', 'O')
('(https://www.', '(https://www.', '.', 'O', 'O')
genomics.
('genomics.', 'genomics.', 'LS', 'B-LST', 'O')
agilent.
('agilent.', 'agilent.', 'LS', 'B-LST', 'O')
com/).
('com/).', 'com/).', 'LS', 'B-LST', 'O')
The vector sequences were confirmed by direct sequencing (SolGent.
('The', 'The', 'DT', 'B-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'B-DNA')
('sequences', 'sequence', 'NNS', 'I-NP', 'I-DNA')
('were', 'be', 'VBD', 'B-VP', 'O')
('confirmed', 'confirm', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('direct', 'direct', 'JJ', 'B-NP', 'O')
('sequencing', 'sequencing', 'NN', 'I-NP', 'O')
('(SolGent.', '(SolGent.', 'NNP', 'B-NP', 'O')
Korea).
('Korea).', 'Korea).', 'NNP', 'B-NP', 'O')
Human embryonic kidney HEK293T were cultured in DMEM with 10% FBS and 1% penicillin streptomycin.
('Human', 'Human', 'JJ', 'B-NP', 'O')
('embryonic', 'embryonic', 'JJ', 'I-NP', 'O')
('kidney', 'kidney', 'NN', 'I-NP', 'O')
('HEK293T', 'HEK293T', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('cultured', 'culture', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('DMEM', 'DMEM', 'NN', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('10%', '10%', 'CD', 'B-NP', 'O')
('FBS', 'FBS', 'NNP', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('1%', '1%', 'CD', 'B-NP', 'O')
('penicillin', 'penicillin', 'NN', 'I-NP', 'O')
('streptomycin.', 'streptomycin.', 'NN', 'I-NP', 'O')
By using a lipofectamine 2000 (Invitrogen Life Technologies, Carlsbad, CA), we transfected the reporter vectors and pRL-TK vector (Promega).
('By', 'By', 'IN', 'B-PP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('lipofectamine', 'lipofectamine', 'NN', 'I-NP', 'O')
('2000', '2000', 'CD', 'I-NP', 'O')
('(Invitrogen', '(Invitrogen', 'NNP', 'I-NP', 'O')
('Life', 'Life', 'NNP', 'I-NP', 'O')
('Technologies,', 'Technologies,', 'NNP', 'I-NP', 'O')
('Carlsbad,', 'Carlsbad,', 'NNP', 'I-NP', 'O')
('CA),', 'CA),', 'NNP', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('transfected', 'transfecte', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('reporter', 'reporter', 'NN', 'I-NP', 'B-DNA')
('vectors', 'vector', 'NNS', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('pRL-TK', 'pRL-TK', 'NN', 'B-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'O')
('(Promega).', '(Promega).', 'NN', 'I-NP', 'O')
The pRLTK vector was used to correct variation in transfection efficiency.
('The', 'The', 'DT', 'B-NP', 'O')
('pRLTK', 'pRLTK', 'NN', 'I-NP', 'B-DNA')
('vector', 'vector', 'NN', 'I-NP', 'I-DNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('correct', 'correct', 'VB', 'I-VP', 'O')
('variation', 'variation', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('transfection', 'transfection', 'NN', 'B-NP', 'O')
('efficiency.', 'efficiency.', 'NN', 'I-NP', 'O')
pGL3 Basic vector was also transfected as control.
('pGL3', 'pGL3', 'NN', 'B-NP', 'O')
('Basic', 'Basic', 'JJ', 'I-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('also', 'also', 'RB', 'I-VP', 'O')
('transfected', 'transfecte', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('control.', 'control.', 'NN', 'B-NP', 'O')
After 48 hours, the cell was washed with PBS, and Dual Luciferase Reporter Assay System (Promega) was used to measure the Firefly and Renilla luciferase activities according to the manufacturer’s method.
('After', 'After', 'IN', 'B-PP', 'O')
('48', '48', 'CD', 'B-NP', 'O')
('hours,', 'hours,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('washed', 'wash', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('PBS,', 'PBS,', 'NN', 'B-NP', 'B-protein')
('and', 'and', 'CC', 'O', 'O')
('Dual', 'Dual', 'JJ', 'B-NP', 'O')
('Luciferase', 'Luciferase', 'NN', 'I-NP', 'B-protein')
('Reporter', 'Reporter', 'NNP', 'I-NP', 'O')
('Assay', 'Assay', 'NNP', 'I-NP', 'O')
('System', 'System', 'NNP', 'I-NP', 'O')
('(Promega)', '(Promega)', 'NNP', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('measure', 'measure', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Firefly', 'Firefly', 'NNP', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('Renilla', 'Renilla', 'NNP', 'I-NP', 'O')
('luciferase', 'luciferase', 'NN', 'I-NP', 'B-protein')
('activities', 'activity', 'NNS', 'I-NP', 'O')
('according', 'accord', 'VBG', 'B-PP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('manufacturer’s', 'manufacturer’', 'NNS', 'I-NP', 'O')
('method.', 'method.', 'NN', 'I-NP', 'O')
Since H1FNT is the testis specific histone gene, so we investigated any genetic variation in promoter region of the H1FNT from Korea population.
('Since', 'Since', 'IN', 'B-SBAR', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('testis', 'testis', 'NN', 'I-NP', 'O')
('specific', 'specific', 'JJ', 'I-NP', 'O')
('histone', 'histone', 'NN', 'I-NP', 'O')
('gene,', 'gene,', 'NN', 'I-NP', 'O')
('so', 'so', 'IN', 'B-SBAR', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('investigated', 'investigate', 'VBD', 'B-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('variation', 'variation', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('promoter', 'promoter', 'NN', 'B-NP', 'B-DNA')
('region', 'region', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('Korea', 'Korea', 'NNP', 'B-NP', 'O')
('population.', 'population.', 'NN', 'I-NP', 'O')
To identify any transcription factors in the polymorphic site of the H1FNT promoter, we did in silico analysis by using the web-based bioinformatic model (http://www.
('To', 'To', 'TO', 'B-VP', 'O')
('identify', 'identify', 'VB', 'I-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'B-protein')
('factors', 'factor', 'NNS', 'I-NP', 'I-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('polymorphic', 'polymorphic', 'JJ', 'I-NP', 'B-DNA')
('site', 'site', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('promoter,', 'promoter,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('did', 'do', 'VBD', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('silico', 'silico', 'NN', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('web-based', 'web-based', 'JJ', 'I-NP', 'O')
('bioinformatic', 'bioinformatic', 'JJ', 'I-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('(http://www.', '(http://www.', '.', 'O', 'O')
cbrc.
('cbrc.', 'cbrc.', 'LS', 'B-LST', 'O')
jp/research/db/TFSEARCH.
('jp/research/db/TFSEARCH.', 'jp/research/db/TFSEARCH.', 'NN', 'B-NP', 'O')
html and http://www.
('html', 'html', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('http://www.', 'http://www.', 'NN', 'I-NP', 'O')
gene regulation.
('gene', 'gene', 'NN', 'B-NP', 'O')
('regulation.', 'regulation.', 'NN', 'I-NP', 'O')
com) (Heinemeyer et al., 1999; Matys et al., 2003).
('com)', 'com)', 'LS', 'B-NP', 'O')
('(Heinemeyer', '(Heinemeyer', 'NNP', 'I-NP', 'B-protein')
('et', 'et', 'NN', 'I-NP', 'I-protein')
('al.,', 'al.,', 'IN', 'B-PP', 'I-protein')
('1999;', '1999;', 'CD', 'B-NP', 'I-protein')
('Matys', 'Matys', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2003).', '2003).', 'CD', 'B-NP', 'O')
There is only one SNP existed at the promoter region which two transcription factors can bind (Fig.
('There', 'There', 'EX', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('only', 'only', 'RB', 'B-NP', 'O')
('one', 'one', 'CD', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('existed', 'exist', 'VBD', 'B-VP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'B-DNA')
('region', 'region', 'NN', 'I-NP', 'I-DNA')
('which', 'which', 'WDT', 'B-NP', 'O')
('two', 'two', 'CD', 'B-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'B-protein')
('factors', 'factor', 'NNS', 'I-NP', 'I-protein')
('can', 'can', 'MD', 'B-VP', 'O')
('bind', 'bind', 'VB', 'I-VP', 'O')
('(Fig.', '(Fig.', 'NNP', 'B-NP', 'B-protein')
1).
('1).', '1).', 'LS', 'B-LST', 'O')
Our in silico analysis showed that HOXA7 and CDX2 can bind to the −1135∼−1125 (＋1 indicate the transcription start site) and −1135∼−1129 region which re2261608 existed.
('Our', 'Our', 'PRP$', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('silico', 'silico', 'NN', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('HOXA7', 'HOXA7', 'NN', 'B-NP', 'B-protein')
('and', 'and', 'CC', 'I-NP', 'O')
('CDX2', 'CDX2', 'NN', 'I-NP', 'B-protein')
('can', 'can', 'MD', 'B-VP', 'O')
('bind', 'bind', 'VB', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('−1135∼−1125', '−1135∼−1125', 'CD', 'I-NP', 'O')
('(＋1', '(＋1', 'NN', 'I-NP', 'O')
('indicate', 'indicate', 'VBP', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'O')
('start', 'start', 'NN', 'I-NP', 'O')
('site)', 'site)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('−1135∼−1129', '−1135∼−1129', 'CD', 'B-NP', 'O')
('region', 'region', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('re2261608', 're2261608', 'NN', 'B-NP', 'O')
('existed.', 'existed.', '.', 'O', 'O')
Therefore, −1129 A to T transversion may alter the transcription factor binding affinity in vivo, and could affect its transcription level.
('Therefore,', 'Therefore,', 'RB', 'B-NP', 'O')
('−1129', '−1129', 'CD', 'I-NP', 'O')
('A', 'A', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('T', 'T', 'NN', 'B-NP', 'O')
('transversion', 'transversion', 'NN', 'I-NP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('alter', 'alter', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'B-protein')
('factor', 'factor', 'NN', 'I-NP', 'I-protein')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinity', 'affinity', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('vivo,', 'vivo,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('could', 'could', 'MD', 'B-VP', 'O')
('affect', 'affect', 'VB', 'I-VP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'O')
('level.', 'level.', 'NN', 'I-NP', 'O')
First, we analyzed the H1FNT −1129A＞T SNP from nonazoospermia (n=229) and fertile (n=203) males.
('First,', 'First,', 'IN', 'B-SBAR', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('analyzed', 'analyze', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('nonazoospermia', 'nonazoospermia', 'NN', 'B-NP', 'O')
('(n=229)', '(n=229)', 'LS', 'B-LST', 'O')
('and', 'and', 'CC', 'O', 'O')
('fertile', 'fertile', 'JJ', 'B-ADJP', 'O')
('(n=203)', '(n=203)', 'LS', 'B-LST', 'O')
('males.', 'males.', '.', 'O', 'O')
The SNP analysis was conducted by pyrosequencing assay for −1129A＞T polymorphisms, and statistical analysis of the −1129A＞T results in fertile and nonazoospermia males are shown in Table 2.
('The', 'The', 'DT', 'B-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('conducted', 'conduct', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('pyrosequencing', 'pyrosequencing', 'NN', 'B-NP', 'O')
('assay', 'assay', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'B-NP', 'B-protein')
('polymorphisms,', 'polymorphisms,', 'NN', 'I-NP', 'I-protein')
('and', 'and', 'CC', 'O', 'O')
('statistical', 'statistical', 'JJ', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('results', 'result', 'VBZ', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('fertile', 'fertile', 'JJ', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('nonazoospermia', 'nonazoospermia', 'JJ', 'I-NP', 'O')
('males', 'male', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('shown', 'show', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Table', 'Table', 'JJ', 'B-NP', 'O')
('2.', '2.', 'CD', 'I-NP', 'O')
The frequencies of the heterozygous −1129A＞T (AT), homozygous −1129A＞T (TT), −1129 (AT＋TT) and T allele in the group with nonazoospermia were statistically significant (p＜0.05).
('The', 'The', 'DT', 'B-NP', 'O')
('frequencies', 'frequency', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('heterozygous', 'heterozygous', 'JJ', 'I-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('(AT),', '(AT),', 'NNP', 'I-NP', 'O')
('homozygous', 'homozygous', 'JJ', 'I-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NNP', 'I-NP', 'O')
('(TT),', '(TT),', 'NNP', 'I-NP', 'O')
('−1129', '−1129', 'NN', 'I-NP', 'O')
('(AT＋TT)', '(AT＋TT)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('T', 'T', 'NN', 'I-NP', 'B-DNA')
('allele', 'allele', 'NN', 'I-NP', 'I-DNA')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('nonazoospermia', 'nonazoospermia', 'NN', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('statistically', 'statistically', 'RB', 'B-ADJP', 'O')
('significant', 'significant', 'JJ', 'I-ADJP', 'O')
('(p＜0.05).', '(p＜0.05).', 'LS', 'B-LST', 'O')
The frequencies of heterozygous −1129A＞T (AT) among the fertile and nonazoospermia were 19.7 and 30.57% (p = 0.0059), respectively and homozygous −1129A＞T (TT) among the fertile and nonazoospermia were 0.5 and 3.05% (p=0.0349), respectively.
('The', 'The', 'DT', 'B-NP', 'O')
('frequencies', 'frequency', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('heterozygous', 'heterozygous', 'JJ', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('(AT)', '(AT)', 'NN', 'I-NP', 'O')
('among', 'among', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('fertile', 'fertile', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('nonazoospermia', 'nonazoospermia', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('19.7', '19.7', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('30.57%', '30.57%', 'CD', 'I-NP', 'O')
('(p', '(p', 'NN', 'I-NP', 'O')
('=', '=', 'SYM', 'B-VP', 'O')
('0.0059),', '0.0059),', 'CD', 'B-NP', 'O')
('respectively', 'respectively', 'RB', 'B-ADVP', 'O')
('and', 'and', 'CC', 'O', 'O')
('homozygous', 'homozygous', 'JJ', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('(TT)', '(TT)', 'NN', 'I-NP', 'O')
('among', 'among', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('fertile', 'fertile', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('nonazoospermia', 'nonazoospermia', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('0.5', '0.5', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('3.05%', '3.05%', 'CD', 'I-NP', 'O')
('(p=0.0349),', '(p=0.0349),', 'NN', 'I-NP', 'O')
('respectively.', 'respectively.', 'NN', 'I-NP', 'O')
The frequencies of −1129 A→T substitution in one or both alleles (AT＋TT) and T allele of nonazoospermia were 33.62 and 18.34%, respectively (p=0.0018 and p=0.0005).
('The', 'The', 'DT', 'B-NP', 'O')
('frequencies', 'frequency', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('−1129', '−1129', 'CD', 'B-NP', 'O')
('A→T', 'A→T', 'NN', 'I-NP', 'O')
('substitution', 'substitution', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('one', 'one', 'CD', 'B-NP', 'O')
('or', 'or', 'CC', 'O', 'O')
('both', 'both', 'DT', 'B-NP', 'O')
('alleles', 'allele', 'NNS', 'I-NP', 'B-DNA')
('(AT＋TT)', '(AT＋TT)', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'I-DNA')
('T', 'T', 'NN', 'B-NP', 'I-DNA')
('allele', 'allele', 'NN', 'B-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('nonazoospermia', 'nonazoospermia', 'NN', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('33.62', '33.62', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('18.34%,', '18.34%,', 'CD', 'I-NP', 'O')
('respectively', 'respectively', 'RB', 'I-NP', 'O')
('(p=0.0018', '(p=0.0018', 'CD', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('p=0.0005).', 'p=0.0005).', 'NN', 'I-NP', 'O')
Genetic analysis of H1FNT −1129A＞T SNP data show that there is strong association of this SNP with nonazoospermia.
('Genetic', 'Genetic', 'JJ', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('show', 'show', 'VBP', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('there', 'there', 'EX', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('strong', 'strong', 'JJ', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'B-protein')
('with', 'with', 'IN', 'B-PP', 'O')
('nonazoospermia.', 'nonazoospermia.', 'JJ', 'B-NP', 'O')
Therefore, we further investigated −1129A/T genotype with sperm cell pathophysiology, and analyzed its association with sperm parameters.
('Therefore,', 'Therefore,', 'RB', 'B-ADVP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('further', 'further', 'RB', 'B-ADVP', 'O')
('investigated', 'investigate', 'VBD', 'B-VP', 'O')
('−1129A/T', '−1129A/T', 'NN', 'B-NP', 'O')
('genotype', 'genotype', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('sperm', 'sperm', 'NN', 'B-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('pathophysiology,', 'pathophysiology,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('analyzed', 'analyze', 'VBD', 'B-VP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('sperm', 'sperm', 'NN', 'B-NP', 'O')
('parameters.', 'parameters.', 'NN', 'I-NP', 'O')
The sperm parameter information was available from non azoospermia (n=144).
('The', 'The', 'DT', 'B-NP', 'O')
('sperm', 'sperm', 'NN', 'I-NP', 'O')
('parameter', 'parameter', 'NN', 'I-NP', 'O')
('information', 'information', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('available', 'available', 'JJ', 'B-ADJP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('non', 'non', 'JJ', 'B-NP', 'O')
('azoospermia', 'azoospermia', 'NN', 'I-NP', 'O')
('(n=144).', '(n=144).', '.', 'O', 'O')
From the analysis of sperm pa  rameter with the−1129A/T genotype, the sperm count, motility, vitality and morphology were not significantly associated with −1129A/T genotype, respectively (p=0.8337, p=0.6153, p=0.5445 and p=0.5243) (Table 3).
('From', 'From', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('sperm', 'sperm', 'NN', 'B-NP', 'O')
('pa', 'pa', 'NN', 'I-NP', 'O')
('rameter', 'rameter', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the−1129A/T', 'the−1129A/T', 'NN', 'B-NP', 'O')
('genotype,', 'genotype,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('sperm', 'sperm', 'NN', 'I-NP', 'O')
('count,', 'count,', 'NN', 'I-NP', 'O')
('motility,', 'motility,', 'NN', 'I-NP', 'O')
('vitality', 'vitality', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('morphology', 'morphology', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('significantly', 'significantly', 'RB', 'I-VP', 'O')
('associated', 'associate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('−1129A/T', '−1129A/T', 'NN', 'B-NP', 'B-protein')
('genotype,', 'genotype,', 'NN', 'I-NP', 'I-protein')
('respectively', 'respectively', 'RB', 'B-ADVP', 'O')
('(p=0.8337,', '(p=0.8337,', 'VBD', 'B-VP', 'O')
('p=0.6153,', 'p=0.6153,', 'NN', 'B-NP', 'O')
('p=0.5445', 'p=0.5445', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('p=0.5243)', 'p=0.5243)', 'NN', 'B-NP', 'O')
('(Table', '(Table', 'JJ', 'B-ADJP', 'O')
('3).', '3).', 'CD', 'B-NP', 'O')
We found that H1FNT −1129A＞T polymorphism was significantly associated with non-azoospermia.
('We', 'We', 'PRP', 'B-NP', 'O')
('found', 'find', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('polymorphism', 'polymorphism', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('significantly', 'significantly', 'RB', 'I-VP', 'O')
('associated', 'associate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('non-azoospermia.', 'non-azoospermia.', 'JJ', 'B-NP', 'O')
Functional promoter assay was performed to investigate any polymorphic effect of −1129 A＞T SNP.
('Functional', 'Functional', 'JJ', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'O')
('assay', 'assay', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('investigate', 'investigate', 'VB', 'I-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('polymorphic', 'polymorphic', 'JJ', 'I-NP', 'O')
('effect', 'effect', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('−1129', '−1129', 'CD', 'B-NP', 'O')
('A＞T', 'A＞T', 'NNP', 'I-NP', 'O')
('SNP.', 'SNP.', 'NNP', 'I-NP', 'O')
For reporter assay, we used three reporters, pGL3-Wild, pGL3Risk and pGL3-Dele (Fig.
('For', 'For', 'IN', 'B-PP', 'O')
('reporter', 'reporter', 'NN', 'B-NP', 'O')
('assay,', 'assay,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('used', 'use', 'VBD', 'B-VP', 'O')
('three', 'three', 'CD', 'B-NP', 'O')
('reporters,', 'reporters,', 'NN', 'I-NP', 'O')
('pGL3-Wild,', 'pGL3-Wild,', 'NN', 'I-NP', 'O')
('pGL3Risk', 'pGL3Risk', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('pGL3-Dele', 'pGL3-Dele', 'NN', 'I-NP', 'O')
('(Fig.', '(Fig.', 'NNP', 'B-NP', 'O')
2A), The dual-luciferase assay showed that the cloning of promoter region (1700bp) of H1FNT into pGL3-basic increased the total luciferase activity, but there is no change of activity between wild (pGL3-Wild) and mutant type (pGL3-Risk) (Fig.
('2A),', '2A),', 'IN', 'B-PP', 'O')
('The', 'The', 'DT', 'B-NP', 'O')
('dual-luciferase', 'dual-luciferase', 'NN', 'I-NP', 'O')
('assay', 'assay', 'NN', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cloning', 'cloning', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('promoter', 'promoter', 'NN', 'B-NP', 'O')
('region', 'region', 'NN', 'I-NP', 'O')
('(1700bp)', '(1700bp)', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('pGL3-basic', 'pGL3-basic', 'JJ', 'B-NP', 'O')
('increased', 'increase', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('total', 'total', 'JJ', 'I-NP', 'O')
('luciferase', 'luciferase', 'NN', 'I-NP', 'O')
('activity,', 'activity,', 'NN', 'I-NP', 'O')
('but', 'but', 'CC', 'O', 'O')
('there', 'there', 'EX', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('change', 'change', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('activity', 'activity', 'NN', 'B-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('wild', 'wild', 'JJ', 'B-NP', 'O')
('(pGL3-Wild)', '(pGL3-Wild)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('mutant', 'mutant', 'JJ', 'B-NP', 'O')
('type', 'type', 'NN', 'I-NP', 'O')
('(pGL3-Risk)', '(pGL3-Risk)', 'NN', 'I-NP', 'O')
('(Fig.', '(Fig.', 'NN', 'I-NP', 'O')
2B).
('2B).', '2B).', 'NN', 'B-NP', 'O')
pGL3-Dele (Deletion) vectors which deleted of transcription binding sites (Δ−1129 to −1135) has also similar activity to other reporters (Fig.
('pGL3-Dele', 'pGL3-Dele', 'NN', 'B-NP', 'O')
('(Deletion)', '(Deletion)', 'NN', 'I-NP', 'O')
('vectors', 'vector', 'NNS', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('deleted', 'delete', 'VBD', 'B-VP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('transcription', 'transcription', 'NN', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('sites', 'site', 'NNS', 'I-NP', 'O')
('(Δ−1129', '(Δ−1129', 'CD', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('−1135)', '−1135)', 'NN', 'B-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('also', 'also', 'RB', 'B-ADVP', 'O')
('similar', 'similar', 'JJ', 'B-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('other', 'other', 'JJ', 'B-NP', 'O')
('reporters', 'reporter', 'NNS', 'I-NP', 'O')
('(Fig.', '(Fig.', 'NNP', 'B-NP', 'O')
2B).
('2B).', '2B).', 'NN', 'B-NP', 'O')
Our study showed that the H1FNT −1129A＞T promoter polymorphism (rs2261608) has strong genetic association with male infertility.
('Our', 'Our', 'PRP$', 'B-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('H1FNT', 'H1FNT', 'NN', 'I-NP', 'B-DNA')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'I-DNA')
('promoter', 'promoter', 'NN', 'I-NP', 'I-DNA')
('polymorphism', 'polymorphism', 'NN', 'I-NP', 'O')
('(rs2261608)', '(rs2261608)', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('strong', 'strong', 'JJ', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility.', 'infertility.', 'NN', 'I-NP', 'O')
We analyzed the clinical significance of this promoter SNP.
('We', 'We', 'PRP', 'B-NP', 'O')
('analyzed', 'analyze', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('clinical', 'clinical', 'JJ', 'I-NP', 'O')
('significance', 'significance', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'B-DNA')
('SNP.', 'SNP.', 'NNP', 'B-NP', 'O')
However, there was no direct association of sperm parameter with this −1129A＞T genotype from non-azoospermia group (n=144).
('However,', 'However,', 'WRB', 'B-ADVP', 'O')
('there', 'there', 'EX', 'B-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('direct', 'direct', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('sperm', 'sperm', 'NN', 'B-NP', 'O')
('parameter', 'parameter', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('genotype', 'genotype', 'NN', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('non-azoospermia', 'non-azoospermia', 'JJ', 'B-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('(n=144).', '(n=144).', '.', 'O', 'O')
Interestingly, our data showed that this SNP is only associated with nonazoospermia group (low quality of spermatozoa in the ejaculate), but not with azoospermia group (no spermatozoa in the ejaculate).
('Interestingly,', 'Interestingly,', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('only', 'only', 'RB', 'I-VP', 'O')
('associated', 'associate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('nonazoospermia', 'nonazoospermia', 'JJ', 'B-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('(low', '(low', 'VBP', 'B-VP', 'O')
('quality', 'quality', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('spermatozoa', 'spermatozoa', 'NN', 'B-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ejaculate),', 'ejaculate),', 'NN', 'I-NP', 'O')
('but', 'but', 'CC', 'B-PP', 'O')
('not', 'not', 'RB', 'B-PP', 'O')
('with', 'with', 'IN', 'I-PP', 'O')
('azoospermia', 'azoospermia', 'NN', 'B-NP', 'O')
('group', 'group', 'NN', 'I-NP', 'O')
('(no', '(no', 'VBP', 'B-VP', 'O')
('spermatozoa', 'spermatozoa', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ejaculate).', 'ejaculate).', 'NN', 'I-NP', 'O')
Therefore, our data suggested that this SNP affect total process of spermatogenesis, but may be in part.
('Therefore,', 'Therefore,', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('suggested', 'suggest', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'B-protein')
('affect', 'affect', 'VB', 'B-VP', 'O')
('total', 'total', 'JJ', 'B-NP', 'O')
('process', 'process', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('spermatogenesis,', 'spermatogenesis,', 'NN', 'B-NP', 'B-protein')
('but', 'but', 'CC', 'O', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('part.', 'part.', 'NN', 'B-NP', 'O')
Further analysis of this genotype with sperm parameters may be required with the expanded subfertile group.
('Further', 'Further', 'JJ', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('genotype', 'genotype', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('sperm', 'sperm', 'NN', 'B-NP', 'O')
('parameters', 'parameter', 'NNS', 'I-NP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('required', 'require', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('expanded', 'expand', 'VBN', 'I-NP', 'O')
('subfertile', 'subfertile', 'JJ', 'I-NP', 'O')
('group.', 'group.', 'NN', 'I-NP', 'O')
Functionally, we expected that this promoter SNP may regulate its transcriptional level.
('Functionally,', 'Functionally,', 'IN', 'B-SBAR', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('expected', 'expect', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('regulate', 'regulate', 'VB', 'I-VP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('transcriptional', 'transcriptional', 'JJ', 'I-NP', 'O')
('level.', 'level.', 'NN', 'I-NP', 'O')
In our plasmid based reporter system, there is no polymorphic effect of this promoter SNP.
('In', 'In', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('plasmid', 'plasmid', 'NN', 'I-NP', 'O')
('based', 'based', 'JJ', 'I-NP', 'O')
('reporter', 'reporter', 'NN', 'I-NP', 'O')
('system,', 'system,', 'NN', 'I-NP', 'O')
('there', 'there', 'EX', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('polymorphic', 'polymorphic', 'JJ', 'I-NP', 'O')
('effect', 'effect', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'B-DNA')
('SNP.', 'SNP.', 'NNP', 'B-NP', 'O')
Our in silico analysis showed two possible transcription factors can bind to the promoter of H1FNT which included this −1129A＞T SNP site.
('Our', 'Our', 'PRP$', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('silico', 'silico', 'NN', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('two', 'two', 'CD', 'B-NP', 'O')
('possible', 'possible', 'JJ', 'I-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'B-protein')
('factors', 'factor', 'NNS', 'I-NP', 'I-protein')
('can', 'can', 'MD', 'B-VP', 'O')
('bind', 'bind', 'VB', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('promoter', 'promoter', 'NN', 'I-NP', 'B-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('included', 'include', 'VBD', 'B-VP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('−1129A＞T', '−1129A＞T', 'NN', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('site.', 'site.', 'NN', 'I-NP', 'O')
The transcriptional regulation of H1FNT may be performed under very complicated condition during spermatogenesis, and so further analysis of H1FNT expression in vivo may be required for the analysis of this genotype.
('The', 'The', 'DT', 'B-NP', 'O')
('transcriptional', 'transcriptional', 'JJ', 'I-NP', 'O')
('regulation', 'regulation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('under', 'under', 'IN', 'B-PP', 'O')
('very', 'very', 'RB', 'B-NP', 'O')
('complicated', 'complicate', 'VBN', 'I-NP', 'O')
('condition', 'condition', 'NN', 'I-NP', 'O')
('during', 'during', 'IN', 'B-PP', 'O')
('spermatogenesis,', 'spermatogenesis,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('so', 'so', 'RB', 'B-ADVP', 'O')
('further', 'further', 'JJ', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('in', 'in', 'FW', 'B-ADVP', 'O')
('vivo', 'vivo', 'FW', 'I-ADVP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('required', 'require', 'VBN', 'I-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('genotype.', 'genotype.', 'NN', 'I-NP', 'O')
Our genetic association study of H1FNT with male infertility is the first positive genetic study with male infertility, especially with nonazoospermia in our knowledge.
('Our', 'Our', 'PRP$', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility', 'infertility', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('first', 'first', 'JJ', 'I-NP', 'O')
('positive', 'positive', 'JJ', 'I-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('male', 'male', 'JJ', 'B-NP', 'O')
('infertility,', 'infertility,', 'NN', 'I-NP', 'O')
('especially', 'especially', 'RB', 'B-ADVP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('nonazoospermia', 'nonazoospermia', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('knowledge.', 'knowledge.', 'NN', 'I-NP', 'O')
Further functional and clinical study of H1FNT may provide its biological significance of spermatogenesis.
('Further', 'Further', 'JJ', 'B-NP', 'O')
('functional', 'functional', 'JJ', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('clinical', 'clinical', 'JJ', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('H1FNT', 'H1FNT', 'NN', 'B-NP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('provide', 'provide', 'VB', 'I-VP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('biological', 'biological', 'JJ', 'I-NP', 'O')
('significance', 'significance', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('spermatogenesis.', 'spermatogenesis.', 'NN', 'B-NP', 'O')
We are very grateful to all members of Department of Urology, Kangnam CHA general hospital, Seoul, Korea for recruiting the infertile males who participated in this study.
('We', 'We', 'PRP', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('very', 'very', 'RB', 'B-ADJP', 'O')
('grateful', 'grateful', 'JJ', 'I-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('all', 'all', 'DT', 'B-NP', 'O')
('members', 'member', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Department', 'Department', 'NNP', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Urology,', 'Urology,', 'NNP', 'B-NP', 'O')
('Kangnam', 'Kangnam', 'NNP', 'I-NP', 'O')
('CHA', 'CHA', 'NNP', 'I-NP', 'O')
('general', 'general', 'JJ', 'I-NP', 'O')
('hospital,', 'hospital,', 'NN', 'I-NP', 'O')
('Seoul,', 'Seoul,', 'NNP', 'I-NP', 'O')
('Korea', 'Korea', 'NNP', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('recruiting', 'recruit', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('infertile', 'infertile', 'JJ', 'I-NP', 'O')
('males', 'male', 'NNS', 'I-NP', 'O')
('who', 'who', 'WP', 'B-NP', 'O')
('participated', 'participate', 'VBD', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study.', 'study.', 'NN', 'I-NP', 'O')
This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (01PJ10PG601GN130002).
('This', 'This', 'DT', 'B-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('supported', 'support', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('grant', 'grant', 'NN', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Korea', 'Korea', 'NNP', 'I-NP', 'O')
('Health', 'Health', 'NNP', 'I-NP', 'O')
('21', '21', 'CD', 'I-NP', 'O')
('R&D', 'R&D', 'NNP', 'I-NP', 'O')
('Project,', 'Project,', 'NNP', 'I-NP', 'O')
('Ministry', 'Ministry', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Health', 'Health', 'NNP', 'B-NP', 'O')
('&', '&', 'CC', 'I-NP', 'O')
('Welfare,', 'Welfare,', 'NNP', 'I-NP', 'O')
('Republic', 'Republic', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Korea', 'Korea', 'NNP', 'B-NP', 'O')
('(01PJ10PG601GN130002).', '(01PJ10PG601GN130002).', 'NNP', 'I-NP', 'O')
